Innovent Biologics Bullish on China Obesity Drug Outlook
Innovent Biologics has reported its first profit even as competition from weight-loss generics looms. Speaking exclusively to Bloomberg’s “The China…
Tag: Innovent
Innovent Shares Jump on First Profit, Obesity Drug Momentum
Innovent Biologics Inc. shares saw their biggest gains in nearly five months, after the Chinese drugmaker posted its first annual…
Lilly Inks Deal with Innovent to Speed Up Early Drug Development
Eli Lilly & Co. is paying $350 million upfront to collaborate with Chinese biotech Innovent Biologics Inc. in developing new…
Takeda Inks Deal With China’s Innovent to Develop Cancer Drugs
Takeda Pharmaceutical Co. has struck a deal with China’s Innovent Biologics Inc. to co-develop cancer therapies, underscoring a surge of…